These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 9415655
21. Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases. Zeller V, Cohen P, Prieur AM, Guillevin L. J Rheumatol; 1996 Aug; 23(8):1424-7. PubMed ID: 8856623 [Abstract] [Full Text] [Related]
22. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Ruperto N, Murray KJ, Gerloni V, Wulffraat N, de Oliveira SK, Falcini F, Dolezalova P, Alessio M, Burgos-Vargas R, Corona F, Vesely R, Foster H, Davidson J, Zulian F, Asplin L, Baildam E, Consuegra JG, Ozdogan H, Saurenmann R, Joos R, Pistorio A, Woo P, Martini A, Pediatric Rheumatology International Trials Organization. Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217 [Abstract] [Full Text] [Related]
23. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review. Qushmaq KA, Chalmers A, Esdaile JM. J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676 [Abstract] [Full Text] [Related]
25. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. Lovell DJ, Reiff A, Jones OY, Schneider R, Nocton J, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Whitmore JB, White B, Giannini EH, Pediatric Rheumatology Collaborative Study Group. Arthritis Rheum; 2006 Jun; 54(6):1987-94. PubMed ID: 16732547 [Abstract] [Full Text] [Related]
26. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group. Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V. Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358 [Abstract] [Full Text] [Related]
28. Etanercept therapy in children with juvenile rheumatoid arthritis. Hung JJ, Huang JL. J Microbiol Immunol Infect; 2005 Dec; 38(6):444-6. PubMed ID: 16341346 [Abstract] [Full Text] [Related]
29. The effectiveness and toxicity of cyclosporin A in rheumatoid arthritis: longitudinal analysis of a population-based registry. Marra CA, Esdaile JM, Guh D, Fisher JH, Chalmers A, Anis AH. Arthritis Rheum; 2001 Jun; 45(3):240-5. PubMed ID: 11409664 [Abstract] [Full Text] [Related]
30. Pilot investigation of naproxen/methotrexate interaction in patients with juvenile rheumatoid arthritis. Wallace CA, Smith AL, Sherry DD. J Rheumatol; 1993 Oct; 20(10):1764-8. PubMed ID: 8295192 [Abstract] [Full Text] [Related]
31. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis. Dolezalová P, Krijt J, Chládek J, Nemcová D, Hoza J. Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631 [Abstract] [Full Text] [Related]
32. Serum osteopontin as a predictive marker of responsiveness to methotrexate in juvenile idiopathic arthritis. Masi L, Ricci L, Zulian F, Del Monte F, Simonini G, Capannini S, De Martino M, Brandi ML, Falcini F. J Rheumatol; 2009 Oct; 36(10):2308-13. PubMed ID: 19684155 [Abstract] [Full Text] [Related]
33. [Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis]. Gubar' EE, Bochkova AG, Bunchuk NV. Ter Arkh; 2008 Oct; 80(5):25-30. PubMed ID: 18590110 [Abstract] [Full Text] [Related]
34. [Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination]. Danieli MG, Fratini M, Rossetti L, Giovagnoni A, Amici F, Danieli G. Recenti Prog Med; 1998 Jan; 89(1):7-13. PubMed ID: 9549386 [Abstract] [Full Text] [Related]
35. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy. Rau R, Schleusser B, Herborn G, Karger T. J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088 [Abstract] [Full Text] [Related]
36. Tolerance of cyclosporine A in children with refractory juvenile rheumatoid arthritis. Ostensen M, Høyeraal HM, Kåss E. J Rheumatol; 1988 Oct; 15(10):1536-8. PubMed ID: 3204600 [Abstract] [Full Text] [Related]
37. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis. Céspedes-Cruz A, Gutiérrez-Suárez R, Pistorio A, Ravelli A, Loy A, Murray KJ, Gerloni V, Wulffraat N, Oliveira S, Walsh J, Penades IC, Alpigiani MG, Lahdenne P, Saad-Magalhães C, Cortis E, Lepore L, Kimura Y, Wouters C, Martini A, Ruperto N, Pediatric Rheumatology International Trials Organization (PRINTO). Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547 [Abstract] [Full Text] [Related]
38. Outcome in juvenile rheumatoid arthritis in India. Aggarwal A, Agarwal V, Danda D, Misra R. Indian Pediatr; 2004 Feb; 41(2):180-4. PubMed ID: 15004305 [Abstract] [Full Text] [Related]
39. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis. Ravelli A, Moretti C, Temporini F, Rossi F, Magni-Manzoni S, Pistorio A, Martini A. Clin Exp Rheumatol; 2002 Feb; 20(4):569-72. PubMed ID: 12175118 [Abstract] [Full Text] [Related]
40. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids. Ramanan AV, Campbell-Webster N, Ota S, Parker S, Tran D, Tyrrell PN, Cameron B, Spiegel L, Schneider R, Laxer RM, Silverman ED, Feldman BM. Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]